![](/img/cover-not-exists.png)
Design and Rationale of the GAUSS-2 Study Trial: A Double-Blind, Ezetimibe-Controlled Phase 3 Study of the Efficacy and Tolerability of Evolocumab (AMG 145) in Subjects With Hypercholesterolemia Who Are Intolerant of Statin Therapy
Cho, Leslie, Rocco, Michael, Colquhoun, David, Sullivan, David, Rosenson, Robert S., Dent, Ricardo, Xue, Allen, Scott, Rob, Wasserman, Scott M, Stroes, ErikVolume:
37
Language:
english
Journal:
Clinical Cardiology
DOI:
10.1002/clc.22248
Date:
March, 2014
File:
PDF, 166 KB
english, 2014